Sebia

Founded in 1967, Sebia is a Global specialty In Vitro Diagnostic leader for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy, Autoimmunity and other rare pathologies. Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in technologies, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.